Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syneos Health Inc (NQ: SYNH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Syneos Health Inc < Previous 1 2 3 4 5 6 7 8 Next > Syneos Health's Debt Overview November 04, 2022 Over the past three months, shares of Syneos Health Inc. (NASDAQ:SYNH) decreased by 62.76%. Before having a look at the importance of debt, let's look at how much debt Syneos Health has. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 04, 2022 Gainers Via Benzinga Looking Into Syneos Health's Recent Short Interest November 04, 2022 Syneos Health's (NASDAQ:SYNH) short percent of float has risen 25.38% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 1.63% of all regular... Via Benzinga Nasdaq Turns Lower; Crude Oil Rises Sharply November 04, 2022 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 04, 2022 Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million. Via Benzinga Expert Ratings for Syneos Health October 05, 2022 Analysts have provided the following ratings for Syneos Health (NASDAQ:SYNH) within the last quarter: Via Benzinga Analyst Ratings for Syneos Health September 12, 2022 Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings: Via Benzinga Stocks That Hit 52-Week Lows On Friday November 04, 2022 Friday's session saw 236 companies set new 52-week lows. Via Benzinga Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session November 04, 2022 Gainers Via Benzinga Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket November 04, 2022 Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. Via Benzinga Syneos Health Reports Third Quarter 2022 Results November 04, 2022 From Syneos Health, Inc. Via GlobeNewswire Earnings Outlook For Syneos Health November 03, 2022 Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health... Via Benzinga Earnings Scheduled For November 4, 2022 November 04, 2022 Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings for... Via Benzinga Syneos Health Adds HUB Patient Suite to Deployment Solutions Business October 27, 2022 Brings Together the Industry’s Most Comprehensive Suite of Modular Patient Services, Optimizing Patient Experience from Prescription to Adherence From Syneos Health, Inc. Via GlobeNewswire Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022 October 21, 2022 From Syneos Health, Inc. Via GlobeNewswire Syneos Health Appoints William E. Klitgaard Independent Director October 14, 2022 From Syneos Health, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 October 18, 2022 Upgrades Via Benzinga Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award October 13, 2022 From Syneos Health, Inc. Via GlobeNewswire Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients October 11, 2022 Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for Clients From Syneos Health, Inc. Via GlobeNewswire Citigroup Maintains Neutral Rating for Syneos Health: Here's What You Need To Know October 05, 2022 Citigroup has decided to maintain its Neutral rating of Syneos Health (NASDAQ:SYNH) and lower its price target from $70.00 to $55.00. Shares of Syneos Health are trading down 3.28% over the last 24... Via Benzinga Syneos Health Releases Annual Sustainability Report October 05, 2022 Report Spotlights Significant Progress Toward Achieving Company’s Environmental, Social and Governance Goals, Including Climate Pledge and DE&I Objectives From Syneos Health, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Monday September 19, 2022 On Monday, 429 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday September 16, 2022 During Friday's session, 574 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 15, 2022 On Thursday, 191 stocks hit new 52-week lows. Via Benzinga Tesla, Meta, NVIDIA And Other Big Losers From Tuesday September 14, 2022 U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday September 14, 2022 During Wednesday's session, 265 companies made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 13, 2022 On Tuesday, 126 companies set new 52-week lows. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 September 14, 2022 Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 September 07, 2022 Upgrades Via Benzinga Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday September 14, 2022 Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.